IONS
IONIS PHARMACEUTICALS INC
+1.89 (+4.21%)46.73USD1.3M成交股數7.8B市值–本益比(近四季)7.1股價營收比-40.7%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 268M-41% | 246M+87% | 203M-10% | 157M+17% | 452M+101% | 132M+10% | 227M-30% | 134M-7% | 225M | 119M | 325M | 144M |
| 營業成本 | 2.7M | 3.0M | – | 2.3M | 4.2M | 1.5M | – | 1.1M | 4.2M | 2.2M | – | 2.2M |
| 毛利 | 265M-41% | 243M+87% | – | 154M+16% | 448M+103% | 130M+11% | – | 133M-7% | 221M | 117M | – | 142M |
| 毛利率 | 99.0% | 98.8% | – | 98.5% | 99.1% | 98.9% | – | 99.2% | 98.2% | 98.2% | – | 98.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 150M | 150M | – | 96.8M | 90.6M | 76.3M | – | 61.6M | 65.1M | 52.6M | – | 70.0M |
| 營業利益 | −102M-173% | −117M-20% | −214M+94% | −160M+8% | 140M-312% | −147M-2% | −111M+1710% | −149M+4% | −66.1M | −150M | −6.1M | −143M |
| 營業利益率 | -38.2% | -47.7% | -105.5% | -102.2% | 30.9% | -111.6% | -48.9% | -111.1% | -29.3% | -125.1% | -1.9% | -99.3% |
| 稅後淨利 | −115M-193% | −92.5M-37% | −229M+120% | −129M-8% | 124M-286% | −147M+3% | −104M+1027% | −140M-5% | −66.3M | −143M | −9.3M | −147M |
| 淨利率 | -42.8% | -37.6% | -112.8% | -82.1% | 27.3% | -111.6% | -46.1% | -105.0% | -29.4% | -119.5% | -2.9% | -102.2% |
| 稀釋 EPS | -0.69-199% | -0.56-40% | -1.41+114% | -0.80-16% | 0.70-256% | -0.93-5% | -0.66+1000% | -0.95-8% | -0.45 | -0.98 | -0.06 | -1.03 |
| 稀釋股數 | 165M | 165M | – | 160M | 182M | 159M | – | 149M | 146M | 146M | – | 143M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 350M | 173M | 372M | 338M | 297M | 264M | 242M | 335M | 294M | 349M | 399M | 352M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 50.8M | 5.6M | 10.0M | 10.5M | 8.5M | 11.5M | 12.5M | 28.5M | 28.7M | 30.3M | 7.4M | 25.6M |
| 總資產 | 3.0B | 3.4B | 3.5B | 3.0B | 3.0B | 2.8B | 3.0B | 3.1B | 2.7B | 2.8B | 3.0B | 2.9B |
| 有息負債 | – | – | 1.3B | – | – | – | 1.2B | – | – | – | 1.2B | – |
| 總負債 | 2.6B | 3.0B | 3.0B | 2.4B | 2.4B | 2.3B | 2.4B | 2.4B | 2.4B | 2.5B | 2.6B | 2.6B |
| 股東權益 | 440M | 491M | 489M | 618M | 632M | 476M | 588M | 662M | 264M | 297M | 387M | 315M |
| 負債比 | 85.3% | 85.8% | 86.1% | 79.6% | 78.8% | 83.1% | 80.4% | 78.5% | 90.2% | 89.3% | 87.1% | 89.2% |
| 淨現金(現金 − 有息負債) | – | – | −956M | – | – | – | −960M | – | – | – | −842M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −793M+426% | – | – | – | −151M+1% | – | – | – | −150M | – | – |
| 資本支出 | – | 21.8M | – | – | – | 12.6M | – | – | – | 4.5M | – | – |
| 自由現金流 | – | −815M+399% | – | – | – | −163M+6% | – | – | – | −154M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -331.0% | – | – | – | -124.1% | – | – | – | -129.2% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 944M
| Ionis Operations | 944M | 100.0% | +33.8% |
|---|
產品／服務2025 年度 · 370M
| Spinraza Royalties | 212M | 57.3% | -1.8% |
|---|---|---|---|
| Wainus Royalties | 49.1M | 13.3% | +142.9% |
| Wainua Joint Development Revenue | 42.1M | 11.4% | -47.0% |
| Other Commercial | 35.0M | 9.5% | -2.1% |
| Other Royalties | 24.2M | 6.5% | +15.0% |
| Dawnzera Sales | 7.8M | 2.1% | – |
| Research And Development Revenue 小計 | 508M | 137.1% | +23.2% |
| Collaborative Agreement Revenue 小計 | 466M | 125.8% | +40.0% |
| Commercial 小計 | 436M | 117.7% | +48.7% |
| Royalty 小計 | 286M | 77.1% | +11.0% |
| 產品 小計 | 115M | 31.1% | – |
| Tryngolza Sales 小計 | 108M | 29.0% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 944M | +33.8% | −381M | -40.4% | -2.38 | −320M |
| FY2024 | 705M | -10.5% | −454M | -64.4% | -3.04 | −546M |
| FY2023 | 788M | +34.1% | −366M | -46.5% | -2.56 | −331M |
| FY2022 | 587M | -27.5% | −270M | -45.9% | -1.90 | −290M |
| FY2021 | 810M | +11.1% | −28.6M | -3.5% | -0.20 | 18.8M |
| FY2020 | 729M | -35.0% | −444M | -60.9% | -3.18 | 772K |
| FY2019 | 1.1B | +87.2% | 278M | 24.8% | 1.90 | 315M |
| FY2018 | 600M | – | 274M | 45.6% | 2.07 | 589M |